Canntab Therapeutics Ltd (PILL.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0050 unch (unch) 10/06/23 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.0050 unch (unch) -
Fiscal Year End Date: 05/31
(Values in thousands)
| 05-2022 | 05-2021 | 05-2020 | 05-2019 | 05-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 691 | 1,491 | 2,090 | 414 | 4,218 |
| Marketable Securities | N/A | N/A | 0 | 1,175 | N/A |
| Receivables | 210 | 207 | 161 | 240 | 170 |
| Inventories | 489 | 1,721 | 906 | N/A | N/A |
| TOTAL | $1,465 | $3,515 | $3,485 | $1,904 | $4,464 |
| Non-Current Assets | |||||
| PPE Net | 1,084 | 2,557 | 1,772 | 343 | 160 |
| Intangibles | 304 | 289 | 252 | 180 | 126 |
| Other Non-Current Assets | 0 | 0 | 0 | 167 | 0 |
| TOTAL | $1,387 | $2,846 | $2,024 | $689 | $286 |
| Total Assets | $2,852 | $6,361 | $5,509 | $2,593 | $4,749 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,360 | 60 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 161 | 1,015 | 962 | 51 | 215 |
| Accrued Expenses | 678 | 289 | 256 | 135 | 58 |
| Other current liabilities | 77 | N/A | N/A | N/A | N/A |
| TOTAL | $2,558 | $1,665 | $1,416 | $232 | $314 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126 | 968 | 40 | N/A | N/A |
| Deferred Revenues | 0 | 41 | 0 | 40 | 40 |
| aiOther Non-Current Liabilities | 278 | 1,105 | 0 | 0 | 0 |
| TOTAL | $606 | $2,427 | $564 | $93 | $133 |
| Total Liabilities | $3,163 | $4,092 | $1,980 | $326 | $447 |
| Shareholders' Equity | |||||
| Common Shares | 13,443 | 11,606 | 9,844 | 6,554 | 6,517 |
| Retained earnings | -16,699 | -13,010 | -8,590 | -5,983 | -3,525 |
| Other shareholders' equity | 0 | 814 | 0 | 0 | 0 |
| TOTAL | $-311 | $2,269 | $3,529 | $2,268 | $4,302 |
| Total Liabilities And Equity | $2,852 | $6,361 | $5,509 | $2,593 | $4,749 |